Understanding how kidney cells communicate in kidney diseases

Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies

NIH-funded research State University New York Stony Brook · NIH-10931223

This study is looking at how certain kidney cells work together and what happens when one type gets damaged, which can lead to serious kidney problems; it's for anyone interested in understanding more about kidney health and finding new ways to help treat kidney diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook NIH-funded
Lab location1 site (Stony Brook, United States)
Project IDNIH-10931223 on NIH RePORTER

What this research studies

This research investigates the interactions between podocytes and parietal epithelial cells in the kidneys, which are crucial for maintaining kidney function. It focuses on how damage to podocytes can lead to kidney diseases like Rapidly Progressive Glomerulonephritis and certain types of Focal Segmental Glomerulosclerosis. The study aims to uncover the mechanisms behind these interactions and the role of specific signaling pathways, particularly the STAT3 pathway, in the progression of kidney damage. By exploring these cellular communications, the research seeks to identify potential therapeutic targets for improving kidney health.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with chronic kidney diseases, particularly those with Rapidly Progressive Glomerulonephritis or specific types of Focal Segmental Glomerulosclerosis.

Not a fit: Patients with acute kidney injuries or those without any form of kidney disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for chronic kidney diseases, potentially improving kidney function and patient outcomes.

How similar studies have performed: While the specific mechanisms being studied are novel, previous research has shown that understanding cellular interactions in kidney diseases can lead to significant advancements in treatment.

Where this research is happening

Stony Brook, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.